SEX HORMONE RESPONSIVE CONDITIONS: HRT Flashcards

1
Q

Perimenopause

A
  • Periods still present in some sort of pattern
  • Age 45
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Post menopause

A
  • 1 year after last period
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Health risks associated with menopause

A
  • Osteoporosis
  • CVD
  • TIIDM
  • Depression
  • Cognitive decline, early dementia
  • Other: dry hair and skin, headaches
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Onset of symptoms

A
  • Female oestrogen levels decline and menstruation ceases
  • Symptoms can start several years before final menstrual period and continue for up to 12 yrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Symptoms

A

Vasomotor symptoms - hot flushes and sweats
Musculoskeletal symptoms - joint and muscle pain
Effect on mood - low mood, anxiety
Urogenital symptoms - vaginal dryness
Sexual difficulties - low sexual desire

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Oestrogens

A
  • Natural Ostrogens (estradiol, estrone and estriol)
  • Synthetic Ostrogens (ethinylestradiol and mestranol)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Progestogens

A

norethisterone
levonorgestrel
desogestrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tibolone

A

ostrogenic, progestogenic and weakly androgenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

HRT risks (cancer)

A

Breast cancer
Endometrial cancer
Ovarian cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Breast Cancer

A
  • Increased risk after 1 year - longer use = higher risk
    → Risk higher in combined HRT over ostrogen only
  • Excess risk persists for more than 10 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Endometrial Cancer

A

Increased risk in oestrogen only
Increased risk in tibolone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ovarian Cancer

A

Small increase which disappears a few years after stopping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

HRT risks (CVD)

A

Venous Thromboembolism
Stroke
Coronary Heart Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Venous Thromboembolism

A

Increase risk of DVT with both ostrogen-only and combined HRT
Increase risk with prolonged bed rest, obesity, trauma, family history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Coronary Heart Disease

A

Increased risk in combined HRT when started more than 10 years after menopause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Stroke

A
  • Slight increase with both ostrogen-only and combined HRT
  • Tibolone increases risk by 2.2 times in first year of treatment
16
Q

HRT (with uterus)

A

Combined - oestrogen + progestogen
- cyclical (sequential)
- continuous
Tibolone avoided in perimenopausal phase or if within 12 months of last menstrual period

17
Q

Cyclical (sequential)

A

for women who are still having monthly bleed, or last period was less than a year ago = require progesterone
* Oestrogen continuously and cyclical progesterone (last 12-14 days of cycle)
- progestogen added to trigger a bleed

18
Q

Continuous

A

for women whos last menstrual period was more than 12 months ago
* Same amount of oestrogen and progestogen everyday

19
Q

HRT (without uterus)

A

e.g. hysterectomy
oestrogen only
If endometriosis occurs - consider an addition of progesterone

20
Q

Gols standard HRT

A
  • Body identical or regulated bio-identical hormones
  • Oestrogen through skin
    o Patch, gel, spray
  • +/- micronized progesterone
  • +/- testosterone – can help to improve mood, energy, stamina
  • Combo of all 3 is not something seen in GP, would be specialist care
21
Q

Woman with uterus - cyclical (sequential) HRT (ORAL)

A

Elleste duet - 1mg or 2mg estradiol + 1mg norethisterone
Prempak-C 0.625mg or 1.25mg conducted oestrogen + norgestrel 150mcg

progestognenic side effects offer:
Femoston 1/10 or 2/10 1mg or 2mg estradiol + dyhydrogesterone 10mg

22
Q

Woman with uterus - Continuous combined HRT (ORAL)

A

Elleste duet conti: 2mg estradiol + 1mg norethisterone
Premique: conjugated oestrogen 655mcg + medoxyprogesterone acetate 5mg
Kilofem: 2mg estradiol + 1mg norethisterone
Tibolone

Progestogenic side effects offer:
Femoston conti: 1mg estradiol + 5mg dydrogesterone

23
Q

Woman with no uterus - oestrogen only (ORAL)

A

Elleste solo: 1mg or 2mg estradiol
Premarin: 0.624 or 1.25mg conjugated oestrogen

24
Woman with uterus - cyclical (sequential) combined (PATCHES)
Evorel Sequi patches: Change TWICE per week 50mcg estradiol + 170mcg norethisterone FemSeven Sequi patches: Change ONCE weekly 50mcg estradiol + 10mcg levonorgestrel
25
Woman with continuous - combined (PATCHES)
Evorel conti patches: chance twice a week 50mcg estradiol + norethisterone if progestognenic side effects offer: Femseven conti patches: change once weekly 50mcg estradiol + 7mcg levonorgestrel
26
oestrogen only (PATCHES)
Evorel patches: change twice per week Estradot patches - change twice per week Oestrogen: 2 measures = standard regime
27
Clonidine
vasomotor symptoms larger side effect profile
28
CI
History of breast cancer or other ostrogen-dependent cancers. Active or recent arterial thromboembolic disease, e.g. angina or MI. Current venous thromboembolism or thrombophlebitis, or history of recurrent VTE Thrombophillic disorder. Undiagnosed vaginal bleeding. Untreated endometrial hyperplasia. Liver disease (with abnormal LFTs). Dubin-Johnson and Rotors syndromes, unless monitored closely (rare genetic disorders leading to increased bilirubin).
29
Lifestyle advice
Eat a healthy balanced diet Maintain a healthy BMI Ensure sufficient dietary calcium (700mg/day) Undertake regular weight-bearing exercise stopping smoking, reducing alcohol intake Treatment optimisation of other conditions
30
Stopping HRT
* Unscheduled vaginal bleeding is common * Choice of gradually or immediately stopping
31
Elective surgery
Stop HRT 4-6 weeks before Reinitiate when fully mobile
32
Non-elective surgery
Prophylactic heparin Graduated compression stockings
33
Reasons to stop HRT
Sudden severe chest pain / breathlessness Unexplained swelling or severe pain in calf of one leg (DVT) Severe stomach pain (hepatotoxicity) Serious neurological effects: Unusual severe, prolonged headache, fainting, first unexplained epileptic seizure, motor disturbances, numbness Hepatitis / jaundice BP > 160 mmHg systolic or 95 mmHg diastolic Prolonged immobility
34
Testosterone
Sexual libido in postmenopausal women Replacement therapy in androgen deficiency (Hypogonadism due to androgen deficiency)
35
Why would testosterone be used in androgen deificnecy
Hypogonadism due to androgen deficiency
36
testosterone side effects
Masculinisation Virilisation in women Acne Anxiety Male pattern baldness -Sexual development in pre-pubescent males
37
Male sex hormone antagonism
Cyproterone